Related Articles
O6-methyl-guanine-DNA methyltransferase methylation and IDH1/2 mutation in small cell lung cancer
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma
Monitoring colorectal cancer following surgery using plasma circulating tumor DNA
Heterogeneous methylation of the O6-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines